Safety Outcomes of Selective Serotonin Reuptake Inhibitors in Adolescent Attention-Deficit/Hyperactivity Disorder with Comorbid Depression: The ASSURE Study - CORRIGENDUM

Psychol Med. 2023 Jul;53(10):4831. doi: 10.1017/S0033291723001022. Epub 2023 Apr 20.
No abstract available

Publication types

  • Published Erratum

MeSH terms

  • Adolescent
  • Attention Deficit Disorder with Hyperactivity* / drug therapy
  • Attention Deficit Disorder with Hyperactivity* / epidemiology
  • Comorbidity
  • Depression
  • Humans
  • Selective Serotonin Reuptake Inhibitors* / adverse effects

Substances

  • Selective Serotonin Reuptake Inhibitors